HAUS7
gene geneOn this page
Also known as UIP1
Summary
HAUS7 (HAUS augmin like complex subunit 7, HGNC:32979) is a protein-coding gene on chromosome Xq28, encoding HAUS augmin-like complex subunit 7 (Q99871). Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. It is a common-essential gene (DepMap: required in 98.3% of cancer cell lines).
This gene encodes a subunit of the augmin complex, which regulates centrosome and mitotic spindle integrity, and is necessary for the completion of cytokinesis. The encoded protein was identified by interaction with ubiquitin C-terminal hydrolase 37. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 55559 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 163 total
- Cancer dependency (DepMap): dependent in 98.3% of screened cell lines (common-essential)
- MANE Select transcript:
NM_001385482
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32979 |
| Approved symbol | HAUS7 |
| Name | HAUS augmin like complex subunit 7 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UIP1 |
| Ensembl gene | ENSG00000213397 |
| Ensembl biotype | protein_coding |
| OMIM | 300540 |
| Entrez | 55559 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 7 protein_coding, 7 protein_coding_CDS_not_defined
ENST00000370210, ENST00000370211, ENST00000435662, ENST00000437046, ENST00000460898, ENST00000464993, ENST00000484394, ENST00000490165, ENST00000490453, ENST00000491286, ENST00000883494, ENST00000883495, ENST00000938287, ENST00000938288
RefSeq mRNA: 3 — MANE Select: NM_001385482
NM_001385481, NM_001385482, NM_001385483
CCDS: CCDS35438
Canonical transcript exons
ENST00000370211 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452099 | 153447668 | 153447909 |
| ENSE00001452115 | 153470450 | 153470576 |
| ENSE00003467268 | 153456493 | 153456651 |
| ENSE00003483626 | 153469146 | 153469261 |
| ENSE00003512167 | 153457137 | 153457228 |
| ENSE00003619701 | 153456265 | 153456364 |
| ENSE00003621000 | 153462610 | 153462671 |
| ENSE00003641405 | 153454394 | 153454508 |
| ENSE00003683692 | 153464988 | 153465055 |
| ENSE00003690617 | 153455542 | 153455766 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 97.36.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8930 / max 28.7072, expressed in 364 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200869 | 8.3708 | 1720 |
| 200873 | 0.5365 | 267 |
| 200872 | 0.3565 | 188 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ascending aorta | UBERON:0001496 | 97.36 | gold quality |
| thoracic aorta | UBERON:0001515 | 97.28 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 96.63 | gold quality |
| popliteal artery | UBERON:0002250 | 96.45 | gold quality |
| tibial artery | UBERON:0007610 | 96.45 | gold quality |
| right coronary artery | UBERON:0001625 | 96.08 | gold quality |
| left coronary artery | UBERON:0001626 | 95.07 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 94.10 | gold quality |
| Ammon’s horn | UBERON:0001954 | 94.06 | gold quality |
| right frontal lobe | UBERON:0002810 | 93.04 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 92.79 | gold quality |
| amygdala | UBERON:0001876 | 92.66 | gold quality |
| temporal lobe | UBERON:0001871 | 92.62 | gold quality |
| caudate nucleus | UBERON:0001873 | 92.60 | gold quality |
| putamen | UBERON:0001874 | 92.45 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 92.36 | gold quality |
| cerebral cortex | UBERON:0000956 | 92.15 | gold quality |
| left uterine tube | UBERON:0001303 | 92.08 | gold quality |
| spleen | UBERON:0002106 | 91.87 | gold quality |
| endocervix | UBERON:0000458 | 91.61 | gold quality |
| apex of heart | UBERON:0002098 | 91.43 | gold quality |
| ectocervix | UBERON:0012249 | 91.38 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.32 | gold quality |
| tibial nerve | UBERON:0001323 | 90.89 | gold quality |
| cortex of kidney | UBERON:0001225 | 90.85 | gold quality |
| frontal cortex | UBERON:0001870 | 90.85 | gold quality |
| metanephros cortex | UBERON:0010533 | 90.79 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.58 | gold quality |
| gall bladder | UBERON:0002110 | 90.45 | gold quality |
| primary visual cortex | UBERON:0002436 | 90.37 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.76 |
| E-CURD-112 | no | 3.69 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CTCF
miRNA regulators (miRDB)
7 targeting HAUS7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-599 | 98.32 | 66.99 | 1037 |
| HSA-MIR-3691-3P | 97.90 | 65.97 | 791 |
| HSA-MIR-1914-5P | 97.83 | 66.21 | 807 |
| HSA-MIR-4529-5P | 96.74 | 65.77 | 569 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 98.3% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 2)
- Discusses transcript evidence for TREX1 and TREX2, as well as readthrough transcripts with upstream loci ATRIP and HAUS7. (PMID:11278605)
- HAUS7 mutation may be associated with chromosome misalignment, resulting in severe oligozoospermia. (PMID:29017965)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | haus7 | ENSDARG00000037432 |
| mus_musculus | Haus7 | ENSMUSG00000031371 |
| rattus_norvegicus | Haus7 | ENSRNOG00000055648 |
Protein
Protein identifiers
HAUS augmin-like complex subunit 7 — Q99871 (reviewed: Q99871)
Alternative names: 26S proteasome-associated UCH37-interacting protein 1, UCHL5-interacting protein, X-linked protein STS1769
All UniProt accessions (3): A6NDA1, Q99871, H7BZF8
UniProt curated annotations — full annotation on UniProt →
Function. Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex.
Subunit / interactions. Component of the HAUS augmin-like complex. The complex interacts with the gamma-tubulin ring complex and this interaction is required for spindle assembly. Interacts with UCHL5. Interacts with EML3 (phosphorylated at ‘Thr-881’).
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Spindle.
Tissue specificity. Detected in spleen, thymus, testis, ovary, small intestine and colon, with highest levels of expression in testis and ovary.
Similarity. Belongs to the HAUS7 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q99871-1 | 1 | yes |
| Q99871-2 | 2 | |
| Q99871-3 | 3 |
RefSeq proteins (3): NP_001372410, NP_001372411, NP_001372412 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029711 | Haus7-like | Family |
UniProt features (8 total): splice variant 3, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7SQK | ELECTRON MICROSCOPY | 8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99871-F1 | 78.59 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 16
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition |
| R-HSA-380259 | Loss of Nlp from mitotic centrosomes |
| R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes |
| R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centrosome |
| R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes |
| R-HSA-5620912 | Anchoring of the basal body to the plasma membrane |
| R-HSA-8854518 | AURKA Activation by TPX2 |
MSigDB gene sets: 120 (showing top):
GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_MICROTUBULE_NUCLEATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GOCC_CENTROSOME, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_ORGANELLE_ASSEMBLY, FISCHER_DREAM_TARGETS, GOBP_SPINDLE_ASSEMBLY, GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOBP_MICROTUBULE_POLYMERIZATION
GO Biological Process (5): centrosome cycle (GO:0007098), regulation of microtubule nucleation (GO:0010968), microtubule organizing center organization (GO:0031023), spindle assembly (GO:0051225), cell division (GO:0051301)
GO Molecular Function (3): thioesterase binding (GO:0031996), microtubule minus-end binding (GO:0051011), protein binding (GO:0005515)
GO Cellular Component (13): nucleolus (GO:0005730), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), ciliary basal body (GO:0036064), HAUS complex (GO:0070652), sperm midpiece (GO:0097225), sperm principal piece (GO:0097228), mitotic spindle microtubule (GO:1990498), cytoplasm (GO:0005737), spindle (GO:0005819), cytoskeleton (GO:0005856), microtubule (GO:0005874)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| G2/M Transition | 2 |
| Centrosome maturation | 2 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 1 |
| Mitotic Prometaphase | 1 |
| Assembly of the 9+0 primary cilium | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| intracellular membraneless organelle | 3 |
| microtubule organizing center | 2 |
| sperm flagellum | 2 |
| microtubule cytoskeleton | 2 |
| cell cycle process | 1 |
| microtubule organizing center organization | 1 |
| microtubule nucleation | 1 |
| regulation of microtubule polymerization | 1 |
| microtubule cytoskeleton organization | 1 |
| microtubule-based process | 1 |
| cellular component organization | 1 |
| spindle organization | 1 |
| chromosome segregation | 1 |
| membraneless organelle assembly | 1 |
| cellular process | 1 |
| enzyme binding | 1 |
| microtubule binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| centriole | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cilium | 1 |
| microtubule associated complex | 1 |
| spindle microtubule | 1 |
| mitotic spindle | 1 |
| intracellular anatomical structure | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
612 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HAUS7 | HAUS6 | Q7Z4H7 | 934 |
| HAUS7 | HAUS2 | Q9NVX0 | 848 |
| HAUS7 | PSMD8 | P48556 | 830 |
| HAUS7 | HAUS1 | Q96CS2 | 810 |
| HAUS7 | UCHL5 | Q9Y5K5 | 808 |
| HAUS7 | HAUS3 | Q68CZ6 | 781 |
| HAUS7 | HAUS5 | O94927 | 771 |
| HAUS7 | HAUS8 | Q9BT25 | 758 |
| HAUS7 | HAUS4 | Q9H6D7 | 711 |
| HAUS7 | TUBG1 | P23258 | 639 |
| HAUS7 | NUMA1 | Q14980 | 639 |
| HAUS7 | TEX28 | O15482 | 510 |
| HAUS7 | ZNF784 | Q8NCA9 | 496 |
| HAUS7 | MTMR1 | Q13613 | 469 |
| HAUS7 | PNCK | Q6P2M8 | 463 |
IntAct
154 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:2364”(proximity) | 0.900 |
| CEP290 | CCP110 | psi-mi:“MI:2364”(proximity) | 0.890 |
| MED29 | MED19 | psi-mi:“MI:0914”(association) | 0.890 |
| HAUS2 | HAUS6 | psi-mi:“MI:0915”(physical association) | 0.880 |
| HAUS1 | HAUS6 | psi-mi:“MI:0915”(physical association) | 0.810 |
| HAUS1 | HAUS5 | psi-mi:“MI:0915”(physical association) | 0.780 |
| HAUS1 | HAUS5 | psi-mi:“MI:0914”(association) | 0.780 |
| HAUS6 | HAUS7 | psi-mi:“MI:0915”(physical association) | 0.770 |
| HAUS2 | HAUS5 | psi-mi:“MI:0914”(association) | 0.730 |
| HAUS6 | HAUS5 | psi-mi:“MI:0914”(association) | 0.710 |
| HAUS4 | HAUS5 | psi-mi:“MI:0914”(association) | 0.640 |
| ARFIP1 | ARL1 | psi-mi:“MI:0914”(association) | 0.640 |
| B3GAT3 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.640 |
| Haus4 | HAUS5 | psi-mi:“MI:0914”(association) | 0.560 |
| DPPA3 | HAUS7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| Haus4 | HAUS5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFS1 | HAUS7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAUS7 | PRPH | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | HAUS7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAUS7 | NUP58 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAJB6 | HAUS7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAUS7 | HTRA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAUS7 | PANK2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (208): HAUS7 (Affinity Capture-MS), HAUS7 (Affinity Capture-MS), HAUS1 (Affinity Capture-MS), ASPM (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), HAUS4 (Affinity Capture-MS), HAUS3 (Affinity Capture-MS), HAUS8 (Affinity Capture-MS), GOLIM4 (Affinity Capture-MS), HAUS5 (Affinity Capture-MS), GLCE (Affinity Capture-MS), CKAP4 (Affinity Capture-MS), FKRP (Affinity Capture-MS), CETN3 (Affinity Capture-MS), SLC27A2 (Affinity Capture-MS)
ESM2 similar proteins: A0A0M3U1B0, A0JMF7, A2RTY3, A4D1B5, D3Z2X2, E9Q8T7, O70173, O88480, Q0VG85, Q1T769, Q3TCV3, Q3U1D0, Q3UHA3, Q3ULW6, Q3UPC7, Q4R744, Q571B6, Q5QNV8, Q5SW28, Q5T4T6, Q5T5N4, Q5XHZ2, Q5XI03, Q63164, Q6P2D8, Q6P4T1, Q7Z2Y8, Q7Z2Z1, Q86UK5, Q86WZ0, Q8BMG1, Q8BQ33, Q8CCC3, Q8CE13, Q8IV33, Q8IXR5, Q8ND61, Q8NG48, Q8TF30, Q920I9
Diamond homologs: Q8BKT8, Q99871
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| HAUS7 | “form complex” | “HAUS complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 138 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | 18 | 35.2× | 1e-21 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 18 | 35.2× | 1e-21 |
| AURKA Activation by TPX2 | 18 | 33.8× | 2e-21 |
| Recruitment of mitotic centrosome proteins and complexes | 18 | 30.2× | 2e-20 |
| Anchoring of the basal body to the plasma membrane | 21 | 29.3× | 3e-23 |
| Regulation of PLK1 Activity at G2/M Transition | 18 | 28.2× | 5e-20 |
| Recruitment of NuMA to mitotic centrosomes | 18 | 25.9× | 2e-19 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| centriole replication | 6 | 36.9× | 2e-06 |
| spindle assembly | 8 | 29.8× | 4e-08 |
| centrosome cycle | 10 | 28.3× | 6e-10 |
| non-motile cilium assembly | 6 | 14.7× | 2e-04 |
| cilium assembly | 11 | 6.8× | 6e-05 |
| cell division | 14 | 5.4× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
163 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 18 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1717 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:153454389:CGTA:C | donor_loss | 1.0000 |
| X:153454390:GTACC:G | donor_loss | 1.0000 |
| X:153454391:TACCT:T | donor_loss | 1.0000 |
| X:153454392:A:AC | donor_gain | 1.0000 |
| X:153454392:A:AT | donor_loss | 1.0000 |
| X:153454393:C:CC | donor_gain | 1.0000 |
| X:153454393:C:CG | donor_loss | 1.0000 |
| X:153454509:C:CC | acceptor_gain | 1.0000 |
| X:153455536:CCTTA:C | donor_loss | 1.0000 |
| X:153455537:CTTA:C | donor_loss | 1.0000 |
| X:153455538:TTACT:T | donor_loss | 1.0000 |
| X:153455539:TA:T | donor_loss | 1.0000 |
| X:153455540:A:AC | donor_gain | 1.0000 |
| X:153455541:C:CA | donor_gain | 1.0000 |
| X:153455541:CT:C | donor_gain | 1.0000 |
| X:153455541:CTTGG:C | donor_gain | 1.0000 |
| X:153455763:AGTA:A | acceptor_gain | 1.0000 |
| X:153455765:TA:T | acceptor_gain | 1.0000 |
| X:153455767:C:CC | acceptor_gain | 1.0000 |
| X:153456259:CCTCA:C | donor_loss | 1.0000 |
| X:153456260:CTCA:C | donor_loss | 1.0000 |
| X:153456263:A:AC | donor_gain | 1.0000 |
| X:153456263:ACCT:A | donor_gain | 1.0000 |
| X:153456264:C:CC | donor_gain | 1.0000 |
| X:153456264:C:CG | donor_loss | 1.0000 |
| X:153456264:CCT:C | donor_gain | 1.0000 |
| X:153456264:CCTC:C | donor_gain | 1.0000 |
| X:153456266:T:TA | donor_gain | 1.0000 |
| X:153456299:T:A | donor_gain | 1.0000 |
| X:153456360:TGGCC:T | acceptor_gain | 1.0000 |
AlphaMissense
2435 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:153469159:A:G | W81R | 0.985 |
| X:153469159:A:T | W81R | 0.985 |
| X:153469157:C:A | W81C | 0.980 |
| X:153469157:C:G | W81C | 0.980 |
| X:153469177:G:T | R75S | 0.979 |
| X:153455656:A:C | F282L | 0.977 |
| X:153455656:A:T | F282L | 0.977 |
| X:153455658:A:G | F282L | 0.977 |
| X:153455669:A:G | L278P | 0.973 |
| X:153457228:C:G | G129R | 0.973 |
| X:153469200:A:G | L67P | 0.971 |
| X:153469176:C:G | R75P | 0.968 |
| X:153469252:A:G | C50R | 0.966 |
| X:153469197:A:T | L68Q | 0.962 |
| X:153457228:C:A | G129C | 0.954 |
| X:153470454:A:G | L45P | 0.952 |
| X:153469167:A:G | I78T | 0.949 |
| X:153469167:A:C | I78S | 0.948 |
| X:153457203:A:G | L137P | 0.947 |
| X:153455657:A:G | F282S | 0.941 |
| X:153469177:G:C | R75G | 0.941 |
| X:153469250:G:C | C50W | 0.941 |
| X:153457205:C:A | Q136H | 0.937 |
| X:153457205:C:G | Q136H | 0.937 |
| X:153469197:A:C | L68R | 0.937 |
| X:153470462:G:C | F42L | 0.927 |
| X:153470462:G:T | F42L | 0.927 |
| X:153470464:A:G | F42L | 0.927 |
| X:153469155:A:C | M82R | 0.926 |
| X:153469158:C:G | W81S | 0.926 |
dbSNP variants (sampled 300 via entrez): RS1000275678 (X:153467256 C>T), RS1000310656 (X:153493604 G>A), RS1000359306 (X:153448287 C>G,T), RS1000381979 (X:153466514 C>A,G), RS1000481498 (X:153474334 G>A), RS1000555923 (X:153462902 T>C), RS1000646317 (X:153481825 A>G), RS1000814907 (X:153448733 G>A,T), RS1000912767 (X:153495027 G>A,C), RS1000995756 (X:153482136 G>T), RS1001157717 (X:153461066 T>A,C,G), RS1001204083 (X:153488511 C>A,T), RS1001381885 (X:153463636 T>G), RS1001505537 (X:153460786 C>T), RS1001583415 (X:153492559 C>A)
Disease associations
OMIM: gene MIM:300540 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 2 |
| Calcitriol | decreases expression, increases expression, affects cotreatment | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | increases expression | 1 |
| NSC 689534 | decreases expression, affects binding | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Troglitazone | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Coumestrol | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Phenobarbital | affects expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
| Urethane | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.